Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
14.10
-0.31 (-2.15%)
Feb 21, 2025, 4:00 PM EST - Market closed
Embecta Market Cap
Embecta has a market cap or net worth of $819.70 million as of February 21, 2025. Its market cap has decreased by -18.18% in one year.
Market Cap
819.70M
Enterprise Value
2.20B
1-Year Change
-18.18%
Ranking
Category
Stock Price
$14.10
Market Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $819.70M, a decrease of -69.37%. That is a compound annual growth rate of -33.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 819.70M | -31.72% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |